Loading company…
Umibio develops products and services for gene editing and exosome testing.
Founded in 2016 and based in Shanghai, China, Umibio focuses on research and product development in gene editing and exosome detection. Its products include engineered exosomes, 293T exosomes, milk exosome extracts and specialized media. In July 2022, the company raised an undisclosed amount in angel funding led by Linear Venture.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in